Swedish oncology firm Elekta of Stockholm has reported that demand for its clinical products and services remained strong in the first six months of fiscal 2010 (end-October 31), with order bookings increasing by 20%.
Net sales increased 10% to 3.13 billion kronor ($444 million U.S.), compared with 2.49 billion kronor ($353 million U.S.) in the first six months of fiscal 2009. Operating profit rose to 321 million kronor ($45 million U.S.), compared with 118 million kronor ($17 million U.S.) in the same time frame in 2009.
Elekta reiterated its financial outlook for net sales growth of more than 8% and operating profit of more than 35% in fiscal 2010.
Related Reading
Elekta nets Russian contract, November 4, 2009
Elekta wins California contract, October 27, 2009
Elekta nets FDA OK for Extend, October 23, 2009
Elekta wins MGH contract, October 2, 2009
Elekta posts healthy Q1 results, September 15, 2009
Copyright © 2009 AuntMinnie.com
